Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

This article sums up the current state of NAVB all too well:

http://newswatchinternational.com/news/company-shares-of-navidea-biopharmaceuticals-inc-nysemktnavb-drops-by-5-67.html

Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB) has lost 5.67% during the past week and dropped 10.74% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 4.89%. Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB) has underperformed the index by 8.65% in the last 4 weeks. Investors should watch out for further signals and trade with caution.

Navidea Biopharmaceuticals, Inc has dropped 41.41% during the last 3-month period . Year-to-Date the stock performance stands at -29.63%.

Shares of Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB) ended Thursday session in red amid volatile trading. The shares closed down 0.01 points or 0.75% at $1.33 with 458,401 shares getting traded. Post opening the session at $1.34, the shares hit an intraday low of $1.32 and an intraday high of $1.37 and the price vacillated in this range throughout the day. The company has a market cap of $207 million and the number of outstanding shares have been calculated to be 155,699,670 shares. The 52-week high of Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB) is $2.495 and the 52-week low is $1.22.

Currently the company Insiders own 2.1% of Navidea Biopharmaceuticals, Inc. shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -10.11% . Institutional Investors own 35.63% of Navidea Biopharmaceuticals, Inc. shares. During last six month period, the net percent change held by insiders has seen a change of -21.95%. On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, The officer (EVP, CFO, Treas & Secy), of Navidea Biopharmaceuticals, Inc., Larson Brent L had unloaded 12,500 shares at $1.5 per share in a transaction on December 1, 2015. The total value of transaction was $18,750. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.